Health
Researchers uncover potentially promising therapeutic combination for renal cell carcinoma – Medical Xpress
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney…
Renal cell carcinoma (RCC) is the most common form of kidney cancer. In 2018, there were an estimated 403,000 new cases of RCC and 175,000 deaths due to kidney cancer worldwide. Currently, the 5-year survival rate for patients with metastatic RCC is only about 12 percent. Current treatments include inhibitors of the VEGF and PD-1 pathways. However, resistance to therapy occurs in most patients and new combination treatments are still needed to enhance the efficacy of these current approaches.
Now,…
-
General19 hours agoRSL NSW president Mick Bainbridge and three board members resign in wake of 7.30 investigation into conflicts of interest
-
General23 hours agoSelf-taught child drummer makes rock band debut with The Living End
-
Noosa News23 hours agoOne Nation leader Pauline Hanson calls out supermarket giants for ‘fleecing’ customers with ‘flimsy’ paper bags
-
Noosa News18 hours agoNorman Dean Lake refused bail for allegedly threatening to kill Prime Minister Anthony Albanese